Andy Warhol Foundation grant to support book completion
Sergio Delgado Moya, associate professor of Spanish and Portuguese, has been awarded one of the Andy Warhol Foundation’s Arts Writer Grants.
Projects supported by the program address both general and specialized art audiences, from scholarly studies to critical reviews and magazine features. Moya will receive $50,000 to complete his book “An Archive of Violence: The Obscene Visuality of Sensationalism.” The book makes a case for sensationalism as a specific kind of violence that falls on marginalized populations who are marked by gender and class, by race and ethnicity, by dispossession and by sexuality.
December 10, 2020 Black women had high rates of health conditions linked to worse breast cancer outcomes in a study published on December 7 in
Cancer. These trends could be contributing to worse breast cancer outcomes for Black women despite years of better treatment options and widespread screening mammography.
The retrospective study, led by Kirsten Nyrop, PhD, looked at differences among 548 Black and white women diagnosed with early-stage breast cancer. Black patients had higher rates of hypertension, high cholesterol, and diabetes at diagnosis, even after the authors adjusted for age and body mass index (BMI) score.
Both obesity and HR+ breast cancers have been rising in the U.S. for decades. While new treatments and widespread screening mammography have resulted in better breast cancer outcomes overall, Black women are still more likely to die from breast cancer than white women.
December 10, 2020
Postmenopausal women may be able to skip some treatments, thereby avoiding some debilitating side effects, new research says.
Roy James Shakespeare/Getty Images
It may be possible for some postmenopausal women to avoid some breast cancer treatment without compromising survival, according to two new studies presented at the San Antonio Breast Cancer Symposium (SABCS), hosted by UT Health San Antonio, the American Association for Cancer Research, and the Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine.
The meeting was held virtually December 8 to 11.
One study found that postmenopausal women with early-stage breast cancer who were at low risk of recurrence can skip chemotherapy after surgery. The other found that older patients may be able to skip radiation therapy following breast-conserving surgery.
Some postmenopausal women with breast cancer do not benefit from chemotherapy when it’s added to hormone therapy, according to initial results of a clinical trial.
The findings apply to postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to a limited number of lymph nodes, and whose recurrence risk is relatively low.
The findings may save tens of thousands of postmenopausal women each year the time, money, and harmful side effects that come with chemotherapy infusions.
This is the first evidence in a randomized phase III trial that postmenopausal women with HR-positive, HER2-negative breast cancer that has spread to one to three lymph nodes can safely forgo chemotherapy if their recurrence score on a genomic tumor tissue test is 25 or less.
RxPONDER: Even More Women May Forgo Chemo for Breast Cancer medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.